期刊文献+

缺血性脑卒中患者血清C反应蛋白与选择素的变化及临床意义 被引量:9

Clinical Significance of Serum C-Reactive Protein and Selectin Levels in Patients with Cerebral Arterial Thrombosis
原文传递
导出
摘要 目的探讨 C 反应蛋白(CRP)、E-选择素和 P-选择素与缺血性脑卒中的关系及临床意义。方法分别应用免疫透射比浊法和 ELISA 方法测定50例缺血性脑卒中患者及30例正常人的 CRP、E-选择素和 P-选择素血清水平。结果缺血性脑卒中患者急性期血清 CRP、E-选择素和 P-选择素水平与恢复期、对照组的相比较显著升高(P<0.01);大面积梗死组(A 组)、中等面积梗死组(B 组)比小面积梗死组(C 组)3种检测指标明显升高,差异均具有统计学意义(P<0.01)。缺血性脑卒中患者急性期 CRP、E-选择素和 P-选择素水平之间均有正相关关系。结论血清 CRP、E-选择素和 P-选择素水平是缺血性脑卒中的有价值的标志物,可作为脑卒中发病进程和病情轻重的判断指标。 Objective To investigate the clinical significance of serum C-reactive protein, E-selectin and P-selectin levels in patients with cerebral arterial thrombosis. Methods 50 patients and 30 normal controls were enrolled. C-reavtive protein was measured by immuno-turbidimetry. Selection E and P levels were measured by enzyme linked immunosorbent assay (ELISA). Results Serum C-reactive protein,E-selectin and P-selectin levels in acute phase patients were significantly higher than those in control and in recovery phase patients ( P 〈 0. 01 ) ; and their levels in macro-( group A ) and middle-infarction group ( group B) were significantly higher than that in small - infarction group( group C). The levels of C- reactice protein, E-selectin and P-selectin were positively correlated with each other. Conclusion The C-reactive protein, E-selectin and P-selectin levels are valuable markers in patients with cerebral arterial thrombosis and can be used as criterion for the prognosis and monitoring these patients.
出处 《临床急诊杂志》 CAS 2008年第3期152-153,共2页 Journal of Clinical Emergency
关键词 缺血性脑卒中 C反应蛋白 选择素 Cerebral arterial thrombosis C-reactive protein Selectin
  • 相关文献

参考文献6

二级参考文献26

  • 1夏文伟,赵薛旭,李作汉.急性缺血性卒中患者外周血中性粒细胞和单核细胞CD11c、CD18的表达[J].中华神经科杂志,2005,38(11):709-710. 被引量:2
  • 2Jabs WJ, Logering BA, Gerke P, et al. Kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol, 2003, 33:152 - 161.
  • 3Shrive AK, Gheetham GM, Holden D, et al. Three dimensional structure of h uman C-reactive protein. Nature Struc Biol, 1996, 3:346 -354.
  • 4Angrawal A, Lee S, Carson M, et al. Site-directed mutagenesis of the phosphocholine-binding site of human C-reactive protein: role of Thr76 and Trp67. J Immunol, 1997, 158:345 -350.
  • 5Pasceri Ⅴ, Willerson JT, Yeh ET. Direct proinflammatory effect of Creactive protein on human endothelial cells. Circulation, 2000, 102:2165 -2168.
  • 6Pasceri Ⅴ, Cheng JS, Willerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation, 2001,103:2531 -2534.
  • 7Torzewki J, Torzewski M, Bower DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol, 1998, 18:1386 - 1392.
  • 8Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood, 1993,82:513 -520.
  • 9Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997: 336:973 -979.
  • 10Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation, 1998, 98:731 -733.

共引文献33051

同被引文献126

引证文献9

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部